|
16/07/2025 |
Evaluation of safety and tolerability of JM-20 with healthy volunteers. Clinical trial Phase I. |
CIDEM |
Registered |
|
10/06/2025 |
Effects of the Adiponexin formulation on the composition of the intestinal microbiome and weight regulation in individuals with a Body Mass Index greater than or equal to 25 |
HHA |
Registered |
|
30/04/2025 |
Effect of the high-precision symbiotic formulation OptiGutPro EDC-HHA02 in treatment of Idiopathic Inflammatory Bowel Disease |
HHA |
Registered |
|
24/03/2025 |
CIMAvax®-EGF in patients with moderate-severe chronic obstructive pulmonary disease (COPD) |
CIM |
Registered |
|
07/03/2025 |
Prevenox Plus versus original Prevenox: Comparison of effects in healthy volunteers |
CPN |
Registered |
|
13/02/2025 |
Nasalferon in respiratory infections in adults. Phase 3 clinical trial. |
CIGB |
Registered |
|
12/02/2025 |
Intranasal chlorpheniramine (0.4%) for the perennial allergic rhinitis (AR) treatment in adults. Phase IV. |
Ferrer |
Registered |
|
27/12/2024 |
Phase II-III study to evaluate the safety and immunogenicity of the pneumococcal vaccine candidate VCN11 in adult participants aged 50 to 74 years. |
FINLAY |
Registered |
|
12/12/2024 |
Efficacy and safety of SURFACEN® administration by tracheal catheterization in preterm neonates with respiratory distress syndrome. Phase II/III |
CENSA |
Registered |
|
04/11/2024 |
Evaluation of the safety and the therapeutic effect of the Guanabana infusion in patients with breast cancer |
SSA |
Registered |
|
06/09/2024 |
Evaluation of the effect and safety of a booster dose of Abdala against COVID-19. |
CIGB |
Registered |
|
22/08/2024 |
Safety and effect of Itolizumab in extracorporeal circulation, phase I/II |
CIM |
Registered |
|
21/08/2024 |
Phase II-III clinical trial to evaluate the vaccine candidate against pneumococcal diseases VCN11 in infants |
FINLAY |
Registered |
|
31/07/2024 |
Effect and safety of the nutritional supplement Diamel Oral Solution® compared with placebo, in patients with diabetic macular edema without involvement of the macular center, treated or not with laser. Phase II |
CATALYSIS |
Registered |
|
21/06/2024 |
Nimotuzumab in Esophagus premalignant lesions |
CIM |
Registered |
|
20/06/2024 |
CIMAvaxEGF in Non Small Cell Lung Cancer. Exploratory Study of Biomarkers |
CIM |
Registered |
|
18/06/2024 |
Exploratory, open and multicenter study of the use of the humanized monoclonal antibody itolizumab (antiCD6) in patients with solid tumors. |
CIM |
Registered |
|
31/05/2024 |
Effect of the prebiotic OCEAN ACTIVES® Fucoidan in promoting a healthy intestinal microbiome |
HHA |
Registered |
|
30/05/2024 |
Effect and Safety of the nebulized surfactant SURFACEN® in the treatment of broncho-obstructive syndrome in children. Exploratory Phase |
CENSA |
Registered |
|
30/05/2024 |
Effect of the probiotic supplement EDC-HHA01 (OptiBiotics Plus) in the treatment of Type 2 Diabetes Mellitus. |
HHA |
Registered |
